Free Trial
→ The case for $20,000 gold before year end (From Stansberry Research) (Ad)tc pixel Free TNON Stock Alerts

Tenon Medical (TNON) Competitors

Tenon Medical logo
$3.70 0.00 (0.00%)
Closing price 10/5/2026 04:00 PM Eastern
Extended Trading
$3.76 +0.06 (+1.68%)
As of 10/5/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

TNON vs. SINT, MBAI, ICCM, NVNO, and INBS

Should you buy Tenon Medical stock or one of its competitors? Tenon Medical's main competitors and comparable companies include Sintx Technologies (SINT), Check-Cap (MBAI), IceCure Medical (ICCM), enVVeno Medical (NVNO), and Intelligent Bio Solutions (INBS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Tenon Medical compare to Sintx Technologies?

Tenon Medical (NASDAQ:TNON) and Sintx Technologies (NASDAQ:SINT) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, media sentiment, valuation, profitability and risk.

Tenon Medical has a net margin of -257.85% compared to Sintx Technologies' net margin of -848.20%. Sintx Technologies' return on equity of -354.44% beat Tenon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Tenon Medical-257.85% -907.60% -124.84%
Sintx Technologies -848.20%-354.44%-115.37%

In the previous week, Sintx Technologies had 7 more articles in the media than Tenon Medical. MarketBeat recorded 10 mentions for Sintx Technologies and 3 mentions for Tenon Medical. Tenon Medical's average media sentiment score of 0.67 beat Sintx Technologies' score of 0.21 indicating that Tenon Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tenon Medical
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Sintx Technologies
1 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Sintx Technologies has lower revenue, but higher earnings than Tenon Medical. Sintx Technologies is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tenon Medical$3.94M0.63-$12.56M-$44.87N/A
Sintx Technologies$1.02M9.23-$10.36M-$4.91N/A

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are held by institutional investors. 17.7% of Tenon Medical shares are held by company insiders. Comparatively, 4.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Sintx Technologies has a consensus price target of $9.50, indicating a potential upside of 335.78%. Given Sintx Technologies' stronger consensus rating and higher probable upside, analysts plainly believe Sintx Technologies is more favorable than Tenon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenon Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Sintx Technologies beats Tenon Medical on 9 of the 15 factors compared between the two stocks.

How does Tenon Medical compare to MBody AI?

Tenon Medical (NASDAQ:TNON) and MBody AI (NASDAQ:MBAI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends.

Tenon Medical has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market. Comparatively, MBody AI has a beta of 0.66, indicating that its stock price is 34% less volatile than the broader market.

MBody AI has lower revenue, but higher earnings than Tenon Medical. MBody AI is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tenon Medical$3.94M0.63-$12.56M-$44.87N/A
MBody AIN/AN/A$4.14M-$14.07N/A

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 1.1% of MBody AI shares are owned by institutional investors. 17.7% of Tenon Medical shares are owned by company insiders. Comparatively, 0.5% of MBody AI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, MBody AI had 5 more articles in the media than Tenon Medical. MarketBeat recorded 8 mentions for MBody AI and 3 mentions for Tenon Medical. MBody AI's average media sentiment score of 1.00 beat Tenon Medical's score of 0.67 indicating that MBody AI is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tenon Medical
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MBody AI
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

MBody AI has a net margin of 0.00% compared to Tenon Medical's net margin of -257.85%. MBody AI's return on equity of 0.00% beat Tenon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Tenon Medical-257.85% -907.60% -124.84%
MBody AI N/A N/A N/A

MBody AI has a consensus target price of $10.00, indicating a potential upside of 226.80%. Given MBody AI's higher probable upside, analysts plainly believe MBody AI is more favorable than Tenon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenon Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
MBody AI
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

MBody AI beats Tenon Medical on 8 of the 13 factors compared between the two stocks.

How does Tenon Medical compare to IceCure Medical?

Tenon Medical (NASDAQ:TNON) and IceCure Medical (NASDAQ:ICCM) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

Tenon Medical has higher revenue and earnings than IceCure Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tenon Medical$3.94M0.63-$12.56M-$44.87N/A
IceCure Medical$3.38M1.56-$15.06M-$8.52N/A

In the previous week, Tenon Medical and Tenon Medical both had 3 articles in the media. Tenon Medical's average media sentiment score of 0.67 beat IceCure Medical's score of 0.00 indicating that Tenon Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tenon Medical
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
IceCure Medical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Tenon Medical has a beta of 1.35, meaning that its stock price is 35% more volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market.

Tenon Medical has a net margin of -257.85% compared to IceCure Medical's net margin of -427.67%. IceCure Medical's return on equity of -174.26% beat Tenon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Tenon Medical-257.85% -907.60% -124.84%
IceCure Medical -427.67%-174.26%-112.58%

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 17.7% of Tenon Medical shares are held by company insiders. Comparatively, 2.4% of IceCure Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

IceCure Medical has a consensus target price of $52.50, suggesting a potential upside of 3,309.09%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Tenon Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenon Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
IceCure Medical
2 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.20

Summary

Tenon Medical beats IceCure Medical on 8 of the 15 factors compared between the two stocks.

How does Tenon Medical compare to enVVeno Medical?

Tenon Medical (NASDAQ:TNON) and enVVeno Medical (NASDAQ:NVNO) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

Tenon Medical has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.29, meaning that its share price is 29% more volatile than the broader market.

In the previous week, Tenon Medical had 2 more articles in the media than enVVeno Medical. MarketBeat recorded 3 mentions for Tenon Medical and 1 mentions for enVVeno Medical. Tenon Medical's average media sentiment score of 0.67 beat enVVeno Medical's score of 0.51 indicating that Tenon Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tenon Medical
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
enVVeno Medical
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tenon Medical has higher revenue and earnings than enVVeno Medical. enVVeno Medical is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tenon Medical$3.94M0.63-$12.56M-$44.87N/A
enVVeno MedicalN/AN/A-$19.47M-$19.33N/A

enVVeno Medical has a net margin of 0.00% compared to Tenon Medical's net margin of -257.85%. enVVeno Medical's return on equity of -62.28% beat Tenon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Tenon Medical-257.85% -907.60% -124.84%
enVVeno Medical N/A -62.28%-56.83%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenon Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
enVVeno Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33

22.7% of Tenon Medical shares are owned by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are owned by institutional investors. 17.7% of Tenon Medical shares are owned by insiders. Comparatively, 15.0% of enVVeno Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

Tenon Medical beats enVVeno Medical on 8 of the 15 factors compared between the two stocks.

How does Tenon Medical compare to Intelligent Bio Solutions?

Intelligent Bio Solutions (NASDAQ:INBS) and Tenon Medical (NASDAQ:TNON) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, risk, valuation, profitability, institutional ownership and earnings.

Intelligent Bio Solutions has higher revenue and earnings than Tenon Medical. Intelligent Bio Solutions is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intelligent Bio Solutions$4.22M1.31-$12.43M-$9.02N/A
Tenon Medical$3.94M0.63-$12.56M-$44.87N/A

In the previous week, Tenon Medical had 3 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 3 mentions for Tenon Medical and 0 mentions for Intelligent Bio Solutions. Tenon Medical's average media sentiment score of 0.67 beat Intelligent Bio Solutions' score of 0.00 indicating that Tenon Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Intelligent Bio Solutions Neutral
Tenon Medical Positive

33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 22.7% of Tenon Medical shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by insiders. Comparatively, 17.7% of Tenon Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Intelligent Bio Solutions has a beta of 4.31, indicating that its stock price is 331% more volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market.

Tenon Medical has a net margin of -257.85% compared to Intelligent Bio Solutions' net margin of -294.88%. Intelligent Bio Solutions' return on equity of -175.35% beat Tenon Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Intelligent Bio Solutions-294.88% -175.35% -91.25%
Tenon Medical -257.85%-907.60%-124.84%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intelligent Bio Solutions
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Tenon Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Intelligent Bio Solutions beats Tenon Medical on 8 of the 15 factors compared between the two stocks.

Get Tenon Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNON and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNON vs. The Competition

Export
MetricTenon MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.47M$5.46B$7.14B$13.26B
Dividend YieldN/A1.79%2.53%17.36%
P/E Ratio-0.0825.76274.3226.20
Price / Sales0.6369.14609.2488.33
Price / CashN/A32.7327.2234.70
Price / Book0.606.0411.236.40
Net Income-$12.56M$146.97M$3.49B$381.07M
7 Day Performance35.53%-0.46%-1.31%-0.28%
1 Month Performance-0.54%-4.28%-5.97%-4.51%
1 Year Performance-90.96%2.07%7.26%1.63%

Tenon Medical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNON
Tenon Medical
1.3001 of 5 stars		$3.70
flat		N/A-91.4%$2.47M$3.94MN/A26
SINT
Sintx Technologies
3.1689 of 5 stars		$1.78
-2.7%		$9.33
+424.3%		-44.7%$7.69M$1.02MN/A32
MBAI
Check-Cap
3.2874 of 5 stars		$5.47
-14.3%		N/AN/A$7.55MN/AN/A85
ICCM
IceCure Medical
2.4886 of 5 stars		$1.87
-4.1%		$52.50
+2,707.5%		-94.7%$6.41M$3.38MN/A66
NVNO
enVVeno Medical
1.442 of 5 stars		$8.66
-4.8%		N/A-76.4%$5.98MN/AN/A33

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:TNON) was last updated on 10/6/2026 by MarketBeat.com Staff.
From Our Partners
This smart glasses tech is bringing the screen to your eyes
Global AI smart-glasses shipments surged 263% in the first half of 2026, and Citi projects the market could re...
The Tomorrow Investor | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel
Musk says UBI is coming. I say it's already here.
Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...
Freedom Financial | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown”
In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi...
Paradigm Press | Sponsoredtc pixel
I've seen this movie before (last time: 17,556%)
My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...
Crypto 101 Media | Sponsoredtc pixel
The case for $20,000 gold before year end
President Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and A...
Stansberry Research | Sponsoredtc pixel
Why major institutions are piling into this digital asset now
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel